Login To Trade  |  About IIFL
  • NIFTY  6980.95  4.6 0.07%
  • SENSEX 22986.12  34.29 0.15%

BioAsia 2016 Commences on a Grand Note Witnessed Largest Ever Traction from the Industry

India Infoline News Service | Mumbai | February 12, 2016 21:34 IST

Around 1300 registered delegates from 50+ countries participated.

Pharma Newsletter, February 8 - 12, 2016

India Infoline News Service | Mumbai | February 12, 2016 21:20 IST

Pharma companies like Sun Pharma, Aurobindo Pharma and Cipla lifted the sentiment in the stock market with good Q3 numbers. Besides, FDA approvals to Dr. Reddys Lab, Aurobindo Pharma and Shilpa Medicares Raichur units getting FDA compliance letter emerged as a booster dose on individual front. Meanwhile, the government announced to start 10 more diagnostic centres to Zica virus. However, the continuous fall in stock markets took a toll on pharma stocks despite impressive Q3 numbers.

MedTrix Healthcare partners with one of top 3 Pharma companies in emerging markets

India Infoline News Service | Mumbai | February 12, 2016 19:16 IST

The patient engagement activity is an effort from global Pharma to improve the way it communicates with patients and offer services in line with patient centricity.

Sun Pharma gains 2%; Q3 net profit at Rs.1420 crore

India Infoline News Service | Mumbai | February 12, 2016 16:27 IST

The company posted a net profit after taxes, minority interest and share of profit of associates of Rs. 14166.00 million for the quarter ended December 31, 2015 as compared to Rs. 3953.30 million for the quarter ended December 31, 2014.

Wockhardt plummets 13% on dismal Q3 results

India Infoline News Service | Mumbai | February 12, 2016 16:09 IST

Wockhardt slumped 17.56% to Rs 721.70 at 12:45 IST on BSE after consolidated net profit fell 82.4% to Rs 60.97 crore on 18.85% fall in total income to Rs 1116.58 crore in Q3 December 2015 over Q3 December 2014.

Vivimed Labs: Q3 numbers expected to surge

India Infoline News Service | Mumbai | February 12, 2016 15:01 IST

IIFL forecasts the companys net revenue for Q3 FY16 to soar to Rs. 355 crore, at a rate of 2.9% yoy and 3.2% qoq.

Sun Pharma Q3 cons net profit at Rs.1,417 crore

India Infoline News Service | Mumbai | February 12, 2016 14:51 IST

Total Income has increased from Rs. 68558.50 mn for the quarter ended December 31, 2014 to Rs. 73013.10 mn for the quarter ended December 31, 2015.

Alkem Labs Q3 net profit at Rs. 189 crore

India Infoline News Service | Mumbai | February 12, 2016 14:47 IST

The total income stands at Rs.1,274.7 crore as against Rs.987.8 Cr (YoY).

Apollo Hospitals Enterprise Q3 net profit at Rs.109.2 crore, up 14.7%

India Infoline News Service | Mumbai | February 12, 2016 13:32 IST

Total income has increased from Rs. 1,208.3 crore for the quarter ended December 31, 2014 to Rs. 1,435.5 crore for the quarter ended December 31, 2015.

Wockhardt whacked 10.3% after Q3 net profit drops sharply

India Infoline News Service | Mumbai | February 12, 2016 10:01 IST

The pharma company reported consolidated net profit of Rs.60.97 crore for the quarter ended December 31, 2015, registering decline of 82.44% yoy.

Genetic testing among women with breast cancer increasing, can impact treatment decisions: study

India Infoline News Service | Mumbai | February 12, 2016 09:07 IST

The study focused on nearly 900 women diagnosed with breast cancer at age 40 or younger. Researchers looked at rates of genetic testing, barriers to testing, and how the test results affected treatment decisions.

Marksans Pharma expected to post robust Q3 numbers

India Infoline News Service | Mumbai | February 11, 2016 22:15 IST

IIFL forecasts the companys net profit for Q3 FY16 to increase to Rs. 38.60 crore, growing at a rate of 39.3% yoy and 10.7% qoq.

Suven Lifesciences: Q3 numbers likely to disappoint

India Infoline News Service | Mumbai | February 11, 2016 22:03 IST

IIFL forecasts the companys net profit for Q3 FY16 to plummet to Rs. 24 crore, at a rate of 31.4% yoy and 4% qoq.

Shilpa Medicare: Q3 number likely to rise yoy; fall qoq

India Infoline News Service | Mumbai | February 11, 2016 21:05 IST

IIFL forecasts the companys net profit for Q3 FY16 to surge to Rs. 23.5 crore, at a rate of 35.3% yoy; however, it is likely to dip 8% qoq.

Vipul Group launches H3U - an Online Healthcare Platform in India

India Infoline News Service | Mumbai | February 11, 2016 16:26 IST

Vipul Group launched H3U, an Online Healthcare Platform in India, that promises to connect and unite patients and healthcare professionals, bringing forth timely access, resource optimization, and informed choices, under one umbrella.

A little healthy! Cipla closed marginally higher despite missing estimates

India Infoline News Service | Mumbai | February 11, 2016 16:09 IST

The company's sales growth was lower than expected, profitability declined and its pre-tax profit falls by 13% in the December quarter.

SeQuent Scientific Q3FY16 revenues up 38% YoY

India Infoline News Service | Mumbai | February 11, 2016 14:59 IST

EBITDA at Rs. 114 million as compared to Rs.5 million in Q3FY15.

Novartis India Q3 net profit at Rs. 59.8 Cr

India Infoline News Service | Mumbai | February 11, 2016 14:55 IST

Net sales in third quarter stood at Rs.183 crore,down 14% from Rs.213 crore in the year-ago period.

Natco Pharma net profit rises 160% in Q3FY16

India Infoline News Service | Mumbai | February 11, 2016 14:18 IST

The company's net sales in third quarter stood at Rs.263.1 crore, up % from Rs.184.3 crore in the year-ago period.

Back to Top

Download IIFL Markets App